mRNA |
TPCA-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.0066 |
0.8 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
LE-135 |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
SRT-1720 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.8 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.8 |
mRNA |
CP724714 |
GDSC1000 |
pan-cancer |
AAC |
-0.0063 |
0.8 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.0062 |
0.8 |
mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.8 |
mRNA |
BIRB 0796 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.8 |